RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
Clinical trial NCT06385873 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06385873
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.